TOKYO - PTC Therapeutics, Inc. (NASDAQ:PTCT) announced Monday that its drug Sephience (sepiapterin) has received approval from the Japanese Ministry of Health, Labor and Welfare for treating ...
Phenylketonuria (PKU) is a correctable inborn error of metabolism which causes lethal intellectual delay and neurobehavioral anomalies. A screening package ...
Previous studies have shown that genotype correlates with biochemical phenotype in treated phenylketonuria. If there is a strong correlation between genotype and intellectual phenotype of untreated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback